QPSM was found to upregulate SERCA2a expression, reduce CaMKII oxidation, and decrease RyR2 phosphorylation levels, suggesting that QPSM alleviates diastolic calcium overload in cardiomyocytes while augmenting SR calcium reserves, thereby reducing AF susceptibility. Here, CAMK2G is linked to atrial fibrillation.